Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.

Chia-Yu ChenShih-Hsin LiangYung-Yeh SuNai-Jung ChiangHui-Ching WangChang-Fang ChiuLi-Tzong ChenLi-Yuan Bai

Published in: PloS one (2020)

The modified GSL therapy can be a promising and affordable treatment for patients with advanced and metastatic pancreatic cancer in Taiwan. A prospective trial of modified GSL for elderly patients is currently ongoing in Taiwan.

Keyphrases

locally advanced
squamous cell carcinoma
newly diagnosed
small cell lung cancer
rectal cancer
clinical trial
neoadjuvant chemotherapy
radiation therapy
stem cells
phase iii
phase ii
bone marrow
mesenchymal stem cells
cell therapy